249 related articles for article (PubMed ID: 31676788)
1. Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.
Eyre R; Alférez DG; Santiago-Gómez A; Spence K; McConnell JC; Hart C; Simões BM; Lefley D; Tulotta C; Storer J; Gurney A; Clarke N; Brown M; Howell SJ; Sims AH; Farnie G; Ottewell PD; Clarke RB
Nat Commun; 2019 Nov; 10(1):5016. PubMed ID: 31676788
[TBL] [Abstract][Full Text] [Related]
2. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain.
Xing F; Kobayashi A; Okuda H; Watabe M; Pai SK; Pandey PR; Hirota S; Wilber A; Mo YY; Moore BE; Liu W; Fukuda K; Iiizumi M; Sharma S; Liu Y; Wu K; Peralta E; Watabe K
EMBO Mol Med; 2013 Mar; 5(3):384-96. PubMed ID: 23495140
[TBL] [Abstract][Full Text] [Related]
3. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.
Tulotta C; Lefley DV; Freeman K; Gregory WM; Hanby AM; Heath PR; Nutter F; Wilkinson JM; Spicer-Hadlington AR; Liu X; Bradbury SMJ; Hambley L; Cookson V; Allocca G; Kruithof de Julio M; Coleman RE; Brown JE; Holen I; Ottewell PD
Clin Cancer Res; 2019 May; 25(9):2769-2782. PubMed ID: 30670488
[TBL] [Abstract][Full Text] [Related]
5. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T
BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104
[TBL] [Abstract][Full Text] [Related]
6. A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment.
Kang J; Choi YJ; Seo BY; Jo U; Park SI; Kim YH; Park KH
Sci Rep; 2019 Jun; 9(1):8726. PubMed ID: 31217507
[TBL] [Abstract][Full Text] [Related]
7. Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling.
Brandolini L; Cristiano L; Fidoamore A; De Pizzol M; Di Giacomo E; Florio TM; Confalone G; Galante A; Cinque B; Benedetti E; Ruffini PA; Cifone MG; Giordano A; Alecci M; Allegretti M; Cimini A
Oncotarget; 2015 Dec; 6(41):43375-94. PubMed ID: 26517518
[TBL] [Abstract][Full Text] [Related]
8. Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.
D'Amico L; Patanè S; Grange C; Bussolati B; Isella C; Fontani L; Godio L; Cilli M; D'Amelio P; Isaia G; Medico E; Ferracini R; Roato I
Br J Cancer; 2013 Jun; 108(12):2525-36. PubMed ID: 23801032
[TBL] [Abstract][Full Text] [Related]
9. The bone microenvironment invigorates metastatic seeds for further dissemination.
Zhang W; Bado IL; Hu J; Wan YW; Wu L; Wang H; Gao Y; Jeong HH; Xu Z; Hao X; Lege BM; Al-Ouran R; Li L; Li J; Yu L; Singh S; Lo HC; Niu M; Liu J; Jiang W; Li Y; Wong STC; Cheng C; Liu Z; Zhang XH
Cell; 2021 Apr; 184(9):2471-2486.e20. PubMed ID: 33878291
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.
French R; Hayward O; Jones S; Yang W; Clarkson R
Mol Cancer; 2015 Dec; 14():209. PubMed ID: 26667821
[TBL] [Abstract][Full Text] [Related]
11. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
[TBL] [Abstract][Full Text] [Related]
12. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.
D'Amico L; Belisario D; Migliardi G; Grange C; Bussolati B; D'Amelio P; Perera T; Dalmasso E; Dalle Carbonare L; Godio L; Comoglio P; Trusolino L; Ferracini R; Roato I
Oncotarget; 2016 Jul; 7(29):45525-45537. PubMed ID: 27322553
[TBL] [Abstract][Full Text] [Related]
13. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
[TBL] [Abstract][Full Text] [Related]
14. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
15. TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis.
Esposito M; Fang C; Cook KC; Park N; Wei Y; Spadazzi C; Bracha D; Gunaratna RT; Laevsky G; DeCoste CJ; Slabodkin H; Brangwynne CP; Cristea IM; Kang Y
Nat Cell Biol; 2021 Mar; 23(3):257-267. PubMed ID: 33723425
[TBL] [Abstract][Full Text] [Related]
16. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
17. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
18. Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling.
Cui Y; Ma W; Lei F; Li Q; Su Y; Lin X; Lin C; Zhang X; Ye L; Wu S; Li J; Yuan Z; Song L
J Pathol; 2016 Jul; 239(3):297-308. PubMed ID: 27060981
[TBL] [Abstract][Full Text] [Related]
19. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
20. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
